China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'XinJiang Hok-kiàn of Pediatric hemato-oncology Engineering program in Acute Lymphoblastic Leukemia (ALL-X-HOPE-2025)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135920
Registration Time: 2026/11/03
Type: Interventional study
Primary Sponsor: Fujian Children's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=276652
Published by HT Digital Content Services with permission from Health Daily Digest....